System analysis based on weighted gene co‐expression analysis identifies SOX7 as a novel regulator of hepatic stellate cell activation and liver fibrosis
The FASEB Journal · 2024
DOI: 10.1096/fj.202302379r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Yuwei Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Liver Cirrhosis, SOXF Transcription Factors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Natural Science Foundation of Jilin Province.
Abstract (Originalsprache)
Hepatic stellate cell (HSC) activation is the essential pathological process of liver fibrosis (LF). The molecular mechanisms regulating HSC activation and LF are incompletely understood. Here, we explored the effect of transcription factor SRY‐related high mobility group box 7 (SOX7) on HSC activation and LF, and the underlying molecular mechanism. We found the expression levels of SOX7 were decreased in human and mouse fibrotic livers, particularly at the fibrotic foci. SOX7 was also downregulated in primary activated HSCs and TGF‐β1 stimulated LX‐2 cells. SOX7 knockdown promoted activation and proliferation of LX‐2 cells while inhibiting their apoptosis. On the other hand, overexpression of SOX7 suppressed the activation and proliferation of HSCs. Mechanistically, SOX7 attenuates HSC activation and LF by decreasing the expression of β‐catenin and phosphorylation of Smad2 and Smad3 induced by TGF‐β1. Furthermore, overexpression of SOX7 using AAV8‐SOX7 mouse models ameliorated the extent of LF in response to CCl 4 treatment in vivo. Collectively, SOX7 suppressed HSC activation and LF. Targeting SOX7, therefore, could be a potential novel strategy to protect against LF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, Jilin, China.
- Key Laboratory of Zoonosis Research, Ministry of Education, The First Hospital of Jilin University, Changchun, Jilin, China.
Förderung
- National Natural Science Foundation of China
- National Natural Science Foundation of Jilin Province
Zitieren
APA
Liu, Y., Wang, X., Wang, Z., Gao, X., Xu, H., Gao, Y., & Niu, J. (2024). System analysis based on weighted gene co‐expression analysis identifies SOX7 as a novel regulator of hepatic stellate cell activation and liver fibrosis. The FASEB Journal. https://doi.org/10.1096/fj.202302379r
Vancouver
Liu Y, Wang X, Wang Z, Gao X, Xu H, Gao Y, et al. System analysis based on weighted gene co‐expression analysis identifies SOX7 as a novel regulator of hepatic stellate cell activation and liver fibrosis. The FASEB Journal. 2024. doi:10.1096/fj.202302379r
BibTeX
@article{Liu2024,
author = {Liu, Yuwei and Wang, Xiaomei and Wang, Zhongfeng and Gao, Xiuzhu and Xu, Hongqin and Gao, Yanhang and Niu, Junqi},
title = {System analysis based on weighted gene co‐expression analysis identifies SOX7 as a novel regulator of hepatic stellate cell activation and liver fibrosis},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202302379r}
}
EUVIMED